Table 2.

Mean (SD) importance of goals when deciding upon anti-emetic medication for the prevention of CINV/RINV

Treatment goals	Physicians N = 375	Oncology nurses N = 186	Patients N = 386
Reducing episodes of emesis	2.4 (1.68)	2.6 (1.52)	3.4 (1.98)
Reducing episodes of nausea	2.9 (1.58)	3.0 (1.55)	3.3 (1.88)
Improving ability of patients to continue normal daily life	3.2 (1.61)	2.7 (1.58)	3.3 (1.96)
Avoiding missed and/or delayed cycles of therapy	3.8 (1.78)	3.9 (1.74)	4.0 (1.93)
Avoiding need for patient to have to swallow pills/tablets/water when feeling sick	5.1 (1.53)	4.9 (1.63)	4.9 (1.94)
Reducing likelihood of health care professional intervention	5.4 (1.62)	5.8 (1.60)	4.4 (1.83)
Reducing overall burden of medication	5.4 (1.56)	5.1 (1.58)	4.6 (1.88)

Data presented are mean rank order on a scale of 1 to 7, where 1 is most desirable and 7 is least desirable. Note that slightly altered wording was used for all seven goals in patient questionnaires

SD standard deviation, CINV/RINV chemotherapy/radiotherapy-induced nausea and vomiting